Transcatheter Aortic Valve Replacement (TAVR)

Type: procedure

Status: FDA Approved

Developer: Edwards Lifesciences, Medtronic

Breakthrough Summary

No summary available.

Mechanism of Action

Details pending.

Year: 2026